C4 Therapeutics Inc (CCCC) — Working Capital to Net Assets Ratio
C4 Therapeutics Inc (CCCC) has a Working Capital to Net Assets ratio of 93.1% as of March 2026. Working capital of $218.12 Million (current assets of $245.37 Million minus current liabilities of $27.25 Million) is measured against net assets of $234.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of C4 Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
C4 Therapeutics Inc Working Capital to Net Assets (2018–2025)
This chart shows how C4 Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 93.1%, reflecting working capital of $218.12 Million against net assets of $234.25 Million USD. See operational self-sufficiency of C4 Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for C4 Therapeutics Inc (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for C4 Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see C4 Therapeutics Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 87.7% | $225.08 Million | $256.59 Million | $258.11 Million | $33.03 Million | ▼ -10.7 pp |
| 2024 | 98.4% | $212.59 Million | $215.99 Million | $257.77 Million | $45.18 Million | ▲ +5.6 pp |
| 2023 | 92.8% | $228.42 Million | $246.11 Million | $271.19 Million | $42.77 Million | ▲ +8.8 pp |
| 2022 | 84.0% | $243.01 Million | $289.23 Million | $287.56 Million | $44.55 Million | ▲ +13.6 pp |
| 2021 | 70.4% | $274.44 Million | $389.61 Million | $325.69 Million | $51.25 Million | ▼ -49.6 pp |
| 2020 | 120.1% | $337.16 Million | $280.79 Million | $381.01 Million | $43.85 Million | ▲ +176.5 pp |
| 2019 | -56.4% | $63.13 Million | $-111.96 Million | $96.77 Million | $33.64 Million | ▲ +68.5 pp |
| 2018 | -124.9% | $99.58 Million | $-79.75 Million | $123.53 Million | $23.95 Million | — |